How Vietnam is saving lives against Covid-19?
Keywords:Covid-19, FTI, Innovation, Management practices, NPIs, Policy, Technologies
It complements Silva (2020b) research, which showed that among 108 well-evaluated countries, the top benchmark nations against Covid-19 are Vietnam, Taiwan, and Thailand. For example, on April 16, 2021 around 3,011,574 lives were officially lost by Covid-19, while Taiwan, Vietnam, and Thailand reported respectively only 11, 35, and 97 fatal cases (WORLDOMETERS, 2021). So, this article main aim is to investigate the Vietnam performance and the management practices used to save lives against Covid19. The research uses an online questionnaire, is descriptive with documentary and bibliographic approaches to identify management practices, including Non Pharmaceutical Interventions (NPIs) adopted against a pandemic. Also the Fatality Total Index (SILVA, 2020b p. 563) was used to compare Vietnam's performance with 43 semifinalist countries. Some results are: 1) 200 NPIs were identified across the world against coronavirus; 2) Among the 44 countries, Vietnam showed the second best performance, after Taiwan; 3) among 107 respondents living in Vietnam, only 5.61% don´t believe that cultural practices are decisive for the low rate of Covid-19 death, while most (94.39%) believe in that. From the group that believe, the most decisive cultural practices were: wear a mask, wash hands, not shake hands, not hug in public and few religious assembly; 4) for 106 respondents living in Vietnam, the ten main policy measures adopted by the National Government that saved lives against the virus are: international travel control, public information campaigns, schools closures, public event cancellations, integration with mass media, restriction on internal movement, effective public-private collaboration, increase the medical and personal equipment capacity, public transport reduction and combat fake news. At the final, ten golden lessons are provided, from 340 policies, measures, programs, projects, innovative products/services identified, with the majority led by the Public Sector (73.5%), followed by Corporations (8.5%), Others (6.5%), Start ups (6.2%), and Universities (5.3%).
ACAPS (2020). COVID-19 Government Measures Dataset. [online] ACAPS. Available at: https://www.acaps.org/covid-19-government-measures-dataset [Accessed 13 Apr. 2021].
Askitas, N., Tatsiramos, K. and Verheyden, B. (2021). Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study. Scientific Reports, 11(1).
Bell, D.M. (2004). Public Health Interventions and SARS Spread, 2003. Emerging Infectious Diseases, [online] 10(11), pp.1900–1906. Doi 10.3201/eid1011.040729
Bo, Y., Guo, C., Lin, C., Zeng, Y., Li, H.B., Zhang, Y., Hossain, M.S., Chan, J.W.M., Yeung, D.W., Kwok, K.O., Wong, S.Y.S., Lau, A.K.H. and Lao, X.Q. (2021). Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020. International Journal of Infectious Diseases, 102, pp.247–253.
Bruns, D.P., Kraguljac, N.V. and Bruns, T.R. (2020). COVID-19: Facts, Cultural Considerations, and Risk of Stigmatization. Journal of Transcultural Nursing, 31(4), p.104365962091772.
CDC (2019a). Nonpharmaceutical Interventions (NPIs) | CDC. [online] www.cdc.gov. Available at: https://www.cdc.gov/nonpharmaceutical-interventions/index.html.
Chuang, J.-H., Huang, A.S., Huang, W.-T., Liu, M.-T., Chou, J.-H., Chang, F.-Y. and Chiu, W.-T. (2012). Nationwide Surveillance of Influenza during the Pandemic (2009–10) and Post-Pandemic (2010–11) Periods in Taiwan. PLoS ONE, [online] 7(4). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335813/ [Accessed 24 Dec. 2020]. Doi 10.1371/journal.pone.0036120
Cowling, B.J., Ali, S.T., Ng, T.W.Y., Tsang, T.K., Li, J.C.M., Fong, M.W., Liao, Q., Kwan, M.Y., Lee, S.L., Chiu, S.S., Wu, J.T., Wu, P. and Leung, G.M. (2020). Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. The Lancet Public Health, [online] 0(0). Doi 10.1016/S2468-2667(20)30090-6. Available at: https://bit.ly/3b37E6Q [Accessed 20 Apr. 2020].
Cui, Y., Zhang, Z.-F., Froines, J., Zhao, J., Wang, H., Yu, S.-Z. and Detels, R. (2003). Air pollution and case fatality of SARS in the People’s Republic of China: an ecologic study. Environmental Health, 2(1). Doi 10.1186/1476-069X-2-15
Dang, T. (2020). Vietnam’s public loudspeaker system: a means of communication to combat COVID-19. [online] New Mandala. Available at: https://www.newmandala.org/vietnams-public-loudspeaker-system-a-means-of-communication-to-combat-covid-19/ [Accessed 19 Apr. 2021].
Deep Knowledge Group (2020). COVID-19 Regional Safety Assessment. [online] DKV. Available at: https://www.dkv.global/covid-19/full-report [Accessed 22 Aug. 2020].
ECDC (2020). Guidelines for the implementation of non- pharmaceutical interventions against COVID-19 Key messages General considerations on NPI to control COVID-19. [online] Stockholm: , pp.1–38. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidelines-non-pharmaceutical-interventions-september-2020.pdf.
Flaxman, S., Mishra, S., Gandy, A. et al. (2020). Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. Doi 10.1038/s41586-020-2405-7
GBD 2017 SDG Collaborators (2018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.The Lancet, [online] 392(10159), pp.2091–2138. Doi 10.1016/s0140-6736(18)32281-5.
Gomes da Silva, J. (2020). Thailand Performance and Best Management Practices that saved lives against Covid-19: a comparison against ten critical countries. International Journal for Innovation Education and Research, 8(11), pp.119–154. Doi 10.31686/ijier.vol8.iss11.2725
Ha, B.T.T., Ngoc Quang, L., Mirzoev, T., Tai, N.T., Thai, P.Q. and Dinh, P.C. (2020). Combating the COVID-19 Epidemic: Experiences from Vietnam. International Journal of Environmental Research and Public Health, 17(9), p.3125.
Holmes, K.V. (2003). SARS coronavirus: a new challenge for prevention and therapy. Journal of Clinical Investigation, 111(11), pp.1605–1609. Doi 10.1172/JCI18819
IMF (2020). Policy Responses to COVID19. [online] IMF. Available at: https://bit.ly/345Ohbj [Accessed 18 Jul. 2020].
IMF (2021). Fiscal Policies Database. [online] IMF. Available at: https://www.imf.org/en/Topics/imf-and-covid19/Fiscal-Policies-Database-in-Response-to-COVID-19 [Accessed 14 Apr. 2021].
Institute of Medicine. (2004). Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Washington, DC: The National Academies Press. Doi 10.17226/10915.
Intermountain Healthcare (2020). What’s the difference between a pandemic, an epidemic, endemic, and an outbreak? [online] intermountainhealthcare.org. Available at: http://bit.ly/3mvJG8s
La, V.-P., Pham, T.-H., Ho, M.-T., Nguyen, M.-H., P. Nguyen, K.-L., Vuong, T.-T., Nguyen, H.-K.T., Tran, T., Khuc, Q., Ho, M.-T. and Vuong, Q.-H. (2020). Policy Response, Social Media and Science Journalism for the Sustainability of the Public Health System Amid the COVID-19 Outbreak: The Vietnam Lessons. Sustainability, 12(7), p.2931.
Le, T.-A.T., Vodden, K., Wu, J. and Atiwesh, G. (2021). Policy Responses to the COVID-19 Pandemic in Vietnam. International Journal of Environmental Research and Public Health, 18(2), p.559.
Legatum Institute (2019). The Legatum Prosperity Index 2019. Thirteenth Edition. [online] The Legatum Prosperity, pp.1–92. Available at: https://bit.ly/31HkCnL [Accessed 25 Aug. 2020].
LePan, N. (2020). Visualizing the History of Pandemics. [online] Visual Capitalist. Available at: https://www.visualcapitalist.com/history-of-pandemics-deadliest/ [Accessed 9 Apr. 2021].
Luatvietnam.vn (2020). LuatVietnam.Vn - Cơ sở dữ liệu văn bản pháp luật lớn nhất Việt Nam. [online] english.luatvietnam.vn. Available at: https://english.luatvietnam.vn/seach-for-documents.html?Keywords=&DocGroupId=1&SearchOptions=1&SearchExact=0&FieldId=12 [Accessed 19 Apr. 2021].
Jian, S.-W., Chen, C.-M., Lee, C.-Y. and Liu, D.-P. (2017). Real-Time Surveillance of Infectious Diseases: Taiwan’s Experience. Health Security, 15(2), pp.144–153. Doi 10.1089/hs.2016.0107
Jian, S.-W., Cheng, H.-Y., Huang, X.-T. and Liu, D.-P. (2020). Contact tracing with digital assistance in Taiwan’s COVID-19 outbreak response. International Journal of Infectious Diseases, 101, pp.348–352. Doi 10.1016/j.ijid.2020.09.1483
Jones, A., (2020). How 'Overreaction' Made Vietnam A Virus Success. [online] BBC News. Available at: https://www.bbc.com/news/world-asia-52628283 [Accessed 3 June 2020].
NTI, JHU and EIU (2019). The Global Health Security Index 2019. Nuclear Threat Initiative (NTI), Johns Hopkins Center for Health Security (JHU) and The Economist Intelligence Unit (EIU). Available at: https://www.ghsindex.org/ [Accessed 20 feb. 2019].
Nguyen, N.H., Van Nguyen, T., Nguyen, A.Q., Van Nguyen, P. and Nguyen, T.N.M. (2020). The first cohort of the COVID-19 patients in Vietnam and the national response to the pandemic. International Journal of Medical Sciences, 17(16), pp.2449–2453.
Numbeo (2020). Health Care Index by Country 2020. [online] www.numbeo.com. Available at: https://bit.ly/347azcP [Accessed 10 Jul. 2020].
OECD (2020). OECD Policy Responses to Coronavirus (COVID-19). [online] www.oecd.org. Available at: https://bit.ly/3o4kuYS [Accessed 18 Jul. 2020].
Emerging and re-emerging infectious diseases – past, present and beyond. MOJ Biol Med., 6(I), pp.5–8.
Our World in Data (2020). Policy Responses to the Coronavirus Pandemic - Statistics and Research. [online] Our World in Data. Available at: https://bit.ly/2H83MXM.
Our World in Data (2021). Coronavirus (COVID-19) Vaccinations - Statistics and Research. [online] Our World in Data. Available at: https://ourworldindata.org/covid-vaccinations [Accessed 17 Apr. 2021].
Pacific, W. (2020). Calibrating long-term non-pharmaceutical interventions for COVID-19 : principles and facilitation tools. apps.who.int. [online] Available at: https://apps.who.int/iris/handle/10665/332099 [Accessed 12 Apr. 2021].
Pang, X. (2003). Evaluation of Control Measures Implemented in the Severe Acute Respiratory Syndrome Outbreak in Beijing, 2003. JAMA, 290(24), p.3215. Doi 10.1001/jama.290.24.3215
Policy (2020). COVID-19 Policy Watch | Tracking governments’ responses to the pandemic. [online] COVID-19 Policy Watch | Tracking governments’ responses to the pandemic. Available at: https://covid19policywatch.org/policies/taiwan [Accessed 26 Dec. 2020].
Silva, J.G. da (2020a). Evolution of COVID19 new cases in 16 countries and Scenarios for Brazil using metaphorical analysis of Board, Inverted Pyramid and Papyri. International Journal for Innovation Education and Research, [online] 8(4), pp.560–607. Doi 10.31686/ijier.vol8.iss4.2314
Silva, J.G. da (2020b). A healthy, innovative, sustainable, transparent, and competitive methodology to identify twenty benchmark countries that saved people lives against Covid-19 during 180 days. International Journal for Innovation Education and Research, [online] 8(10), pp.541–577. Doi 10.31686/ijier.vol8.iss10.2710
Silva, J.G. da (2021). Ten golden lessons from Republic of China (Taiwan), the best country to save lives during 300 days battle against Covid-19. International Journal for Innovation Education and Research, [online] 9(1), pp.425–474. Doi 10.31686/ijier.vol9.iss1.2915
Svoboda, T., Henry, B., Shulman, L., Kennedy, E., Rea, E., Ng, W., Wallington, T., Yaffe, B., Gournis, E., Vicencio, E., Basrur, S. and Glazier, R.H. (2004). Public Health Measures to Control the Spread of the Severe Acute Respiratory Syndrome during the Outbreak in Toronto. New England Journal of Medicine, 350(23), pp.2352–2361. Doi 10.1056/NEJMoa032111
The Government of The Socialist Republic of Viet Nam (2020). VGP News | COVID-19 Fight. [online] news.chinhphu.vn. Available at: http://news.chinhphu.vn/Home/2019-nCoV-combat.vgp.
The Government of The Socialist Republic of Viet Nam Ministry of Health (2020). TRANG CHỦ - Bộ Y tế - Trang tin về dịch bệnh viêm đường hô hấp cấp COVID-19. [online] Moh.gov.vn. Available at: https://ncov.moh.gov.vn/.
Tran, T.P.T., Le, T.H., Nguyen, T.N.P. and Hoang, V.M. (2020). Rapid response to the COVID-19 pandemic: Vietnam government’s experience and preliminary success. Journal of Global Health, [online] 10(2). Doi 10.7189/jogh.10.020502. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567433/ [Accessed 11 Feb. 2021].
Van Nguyen, H., Van Hoang, M., Dao, A.T.M., Nguyen, H.L., Van Nguyen, T., Nguyen, P.T., Khuong, L.Q., Le, P.M. and Gilmour, S. (2020). An adaptive model of health system organization and responses helped Vietnam to successfully halt the Covid‐19 pandemic: What lessons can be learned from a resource‐constrained country. The International Journal of Health Planning and Management, 35(5), pp.988–992.
Xinhua (2020). International visitors to Vietnam hit record high in 2019 - Xinhua | English.news.cn. [online] www.xinhuanet.com. Available at: http://www.xinhuanet.com/english/2020-01/03/c_138675931.htm [Accessed 20 Apr. 2021].
Zambrano-Monserrate, M.A., Ruano, M.A. and Sanchez-Alcalde, L. (2020). Indirect effects of COVID-19 on the environment. Science of The Total Environment, 728 (138813), pp.1–4. Doi 10.1016/j.scitotenv.2020.138813
Yeh, M.-J. and Cheng, Y. (2020). Policies Tackling the COVID-19 Pandemic: A Sociopolitical Perspective from Taiwan. Health Security, 18(6). Doi 10.1089/hs.2020.0095
Yen, M.-Y., Lin, Y.-E., Lee, C.-H., Ho, M.-S., Huang, F.-Y., Chang, S.-C. and Liu, Y.-C. (2011). Taiwan’s traffic control bundle and the elimination of nosocomial severe acute respiratory syndrome among healthcare workers. Journal of Hospital Infection, 77(4), pp.332–337. Doi 10.1016/j.jhin.2010.12.002
Yen, M.-Y., Chiu, A.W.-H., Schwartz, J., King, C.-C., Lin, Y.E., Chang, S.-C., Armstrong, D. and Hsueh, P.-R. (2014). From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic. Journal of Hospital Infection, 87(4), pp.185–193. Doi 10.1016/j.jhin.2014.05.005
Watts, J. (2003). Report details lessons from SARS outbreak. The Lancet, 362 (9391), p.1207. Doi 10.1016/s0140-6736(03)14561-8.
Wang, C.J., Ng, C.Y. and Brook, R.H. (2020). Response to COVID-19 in Taiwan. JAMA, 323(14). doi:10.1001/jama.2020.3151
WHO (2019). WHO | Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza. [online] WHO. Available at: https://www.who.int/influenza/publications/public_health_measures/publication/en/.
WHO (2020). Naming the coronavirus disease (COVID-19) and the virus that causes it. [online] World Health Organization. Available at: https://bit.ly/30xIpWt [Accessed 18 Aug. 2020].
WHO (2020b). Overview of Public Health and Social Measures in the context of COVID-19. [online] www.who.int. Available at: https://bit.ly/2T4fkxC [Accessed 22 Sep. 2020].
WHO (2021). COVID-19 Situation reports in Viet Nam. [online] www.who.int. Available at: https://www.who.int/vietnam/emergencies/coronavirus-disease-(covid-19)-in-viet-nam/covid-19-situation-reports-in-viet-nam [Accessed 18 Apr. 2021].
Worldometer (2021). Coronavirus Toll Update: Cases & Deaths by Country of Wuhan, China Virus - Worldometer. [online] Worldometers.info. Available at: https://www.worldometers.info/coronavirus/
How to Cite
Copyright (c) 2021 Jonas Gomes da Silva
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.